YY1AP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.206600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.273200E-01
Normal-vs-Stage2
9.518200E-01
Normal-vs-Stage3
2.497800E-01
Normal-vs-Stage4
1.829800E-01
Stage1-vs-Stage2
9.725400E-01
Stage1-vs-Stage3
1.652560E-01
Stage1-vs-Stage4
9.961900E-02
Stage2-vs-Stage3
1.062170E-01
Stage2-vs-Stage4
1.038390E-01
Stage3-vs-Stage4
2.625600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.986600E-01
Normal-vs-AfricanAmerican
9.445000E-01
Normal-vs-Asian
8.150400E-01
Caucasian-vs-AfricanAmerican
8.046800E-01
Caucasian-vs-Asian
4.421200E-01
AfricanAmerican-vs-Asian
7.200600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.486000E-01
Normal-vs-Female
7.407000E-01
Male-vs-Female
1.476360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.509400E-01
Normal-vs-Age(41-60Yrs)
7.276200E-01
Normal-vs-Age(61-80Yrs)
7.936400E-01
Normal-vs-Age(81-100Yrs)
7.141400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.635200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.319800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.944800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.907500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.871840E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.848600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.735800E-01
Normal-vs-Daily Drinker
5.842000E-01
Normal-vs-Weekly Drinker
9.382200E-01
Normal-vs-Occasional Drinker
4.943600E-01
Normal-vs-Social Drinker
8.113600E-01
Non Drinker-vs-Daily Drinker
6.922800E-01
Non Drinker-vs-Weekly Drinker
4.987800E-01
Non Drinker-vs-Occasional Drinker
6.778300E-02
Non Drinker-vs-Social Drinker
8.322000E-01
Daily Drinker-vs-Weekly Drinker
2.889000E-01
Daily Drinker-vs-Occasional Drinker
2.108300E-02
Daily Drinker-vs-Social Drinker
5.304800E-01
Weekly Drinker-vs-Occasional Drinker
3.398600E-01
Weekly Drinker-vs-Social Drinker
6.220800E-01
Occasional Drinker-vs-Social Drinker
1.000580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.559200E-01
Normal-vs-Grade 2
6.042400E-02
Normal-vs-Grade 3
5.395200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.745500E-02
Grade 1-vs-Grade 3
4.047600E-02
Grade 1-vs-Grade 4
6.559200E-01
Grade 2-vs-Grade 3
9.073000E-01
Grade 2-vs-Grade 4
6.042400E-02
Grade 3-vs-Grade 4
5.395200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.105800E-01
Normal-vs-NonDiabetic
9.757800E-01
Diabetic-vs-NonDiabetic
4.550800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.515800E-01
Normal-vs-NoPancreatitis
8.621600E-01
Pancreatitis-vs-NoPancreatitis
1.721980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.451600E-01
Normal-vs-N1
8.478400E-01
N0-vs-N1
1.935620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.423400E-01
Normal-vs-TP53-NonMutant
9.084600E-01
TP53-Mutant-vs-TP53-NonMutant
2.013200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
